FFX
Click for more information
0.00% 20.0¢ firefinch limited

Ann: Presentation -A$47M Equity Raising to Drive Ramp-up atMorila, page-121

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. sirhsv
    972 Posts.
    lightbulb Created with Sketch. 160
    clock Created with Sketch.
    25/06/21
    08:44
    Post #: 54060031
    Looks like the 200k pay rise that directors got, was worth it..

    So pissed about the dilution. Greatvsyrategy for "increasing shareholder wealth".

    It would be interesting to see the company email inbox this morning.

    I concur with Sanchez 's post. Retail holders left holding the bag...

    Ripped off again bu Euroz...

    How long will it take us to get away from the 100 million share overhang now?
    Last edited by sirhsv: 25/06/21
    FFX Price at posting: 45.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
SBW Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add FFX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.